Healthcare Sales & Marketing Network News: Parkinson's disease

Searching News Database: Parkinson's disease

HSMN NewsFeed - 30 Oct 2024
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 15 Jul 2024
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Mar 2024
Insightec's Groundbreaking Transcranial MR-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Devices Neurology Reimbursement

HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 19 Jan 2023
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2022
INSIGHTEC Announces Positive Coverage Decision by Anthem for MR-Guided Focused Ultrasound to Treat Essential Tremor
Devices Neurology Reimbursement

HSMN NewsFeed - 20 Dec 2022
Insightec Receives FDA Approval to Treat Essential Tremor Patients' Second Side, Expanding Total Available Market in United States
Devices Neurology FDA

HSMN NewsFeed - 2 Dec 2022
SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 26 Aug 2022
Inhibikase Therapeutics Announces FDA Clearance of Investigational New Drug Application for IkT-001Pro for the Treatment of Chronic Myelogenous Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 20 Apr 2022
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
Biopharmaceuticals

HSMN NewsFeed - 12 Apr 2022
Neuron23 Appoints Sam Jackson, M.D., MBA, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 14 Feb 2022
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Biopharmaceuticals Neurology FDA Product Launch

HSMN NewsFeed - 10 Feb 2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 3 Feb 2022
First US Commercial Patient Treated for Prostate Disease with Insightec Incisionless Focused Ultrasound System
Devices Urology

HSMN NewsFeed - 11 Jan 2022
Nine Square Therapeutics Appoints Robert Paul as CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 2 Dec 2021
UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Dec 2021
Insightec Announces FDA Clearance For Exablate Prostate To Treat Prostate Tissue
Devices Urology FDA

HSMN NewsFeed - 9 Nov 2021
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 3 Nov 2021
Insightec Announces FDA Approval of Exablate Neuro for the Treatment of Parkinson's Disease
Devices Neurology FDA

HSMN NewsFeed - 2 Nov 2021
Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense(TM) Data in Rune's Software for Precision Neurology
Devices Neurology

HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Biopharmaceuticals

HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 9 Aug 2021
SpinTech Receives FDA 510(k) Clearance for STAGE Technology
Devices Radiology Neurology FDA

HSMN NewsFeed - 5 Aug 2021
KalGene Pharmaceuticals Inc. an Alzheimer's focused company using a next generation engineered drug candidate, has appointed new leadership
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 26 Jul 2021
BlueRock Therapeutics Announces New Board Chair, New President and CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 21 Jul 2021
Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jul 2021
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 13 Jul 2021
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 23 Jun 2021
Caryn Peterson Joins Aspen Neuroscience Board of Directors
Devices Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 7 Jun 2021
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology FDA

HSMN NewsFeed - 12 May 2021
ViewMind Inc Announces Appointment of Chief Executive Officer
Diagnostics Neurology Personnel

HSMN NewsFeed - 30 Apr 2021
Blue Therapeutics announces Series A raise
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
Devices Neurology Personnel

HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 22 Mar 2021
Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology Regulatory

HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch

HSMN NewsFeed - 24 Feb 2021
SpinTech Acquires MR Innovations
Devices Radiology Neurology Mergers & Acquisitions

HSMN NewsFeed - 1 Feb 2021
New Scientific Publications Show Diadem's Blood-Based AlzoSure(R) Biomarker Test Can Predict Which Patients Will Progress to Alzheimer's Disease Years Before Symptoms Occur
Diagnostics Neurology

HSMN NewsFeed - 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Devices Neurology FDA

HSMN NewsFeed - 15 Jan 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
Devices Neurology Venture Capital

HSMN NewsFeed - 16 Dec 2020
Neuron23(TM) Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery

HSMN NewsFeed - 16 Oct 2020
Enterin Announces Appointment of New CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 26 Aug 2020
Clene Nanomedicine Raises Series D Financing of $42.5 Million
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 26 Aug 2020
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
Diagnostics Neurology

HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA

HSMN NewsFeed - 21 Jul 2020
Data from Lilly at Alzheimer's Association International Conference 2020(R) (AAIC 2020) to Showcase Clinical Advances in Alzheimer's Research
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 31 Mar 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jan 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Devices Neurology FDA

HSMN NewsFeed - 8 Jan 2020
Martin Jönsson Appointed New CEO of AlzeCure Pharma
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 7 Nov 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2019
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) THIN LIQUID (barium sulfate) for oral suspension
Biopharmaceuticals Radiology Gastroenterology FDA

HSMN NewsFeed - 31 Jul 2019
Biohaven Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Jul 2019
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator(R) Device for Non-Invasive Treatment of Spasticity
Devices Neurology

HSMN NewsFeed - 22 Jul 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 May 2019
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
Devices Regulatory

HSMN NewsFeed - 1 May 2019
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 25 Feb 2019
INSIGHTEC Announces Expansion of Positive Insurance Coverage for MR-guided Focused Ultrasound to Treat Essential Tremor
Devices Neurosurgery Reimbursement

HSMN NewsFeed - 17 Jan 2019
Asceneuron Appoints Peter Van Vlasselaer as Chairman
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 4 Jan 2019
Allevion Therapeutics Hires New CEO and Initiates Series A Funding
Devices Personnel

HSMN NewsFeed - 14 Dec 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 12 Nov 2018
Collidion Announces Settlement of Sonoma Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 9 Nov 2018
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Nov 2018
BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 25 Oct 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 3 Oct 2018
Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 21 Aug 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Aug 2018
Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
Devices Neurology FDA

HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 9 Jul 2018
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
Biopharmaceuticals Neurology Generics Product Launch

HSMN NewsFeed - 6 Jul 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Jun 2018
Intec Pharma Appoints William Bradley Hayes to Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 20 Jun 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 14 May 2018
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 7 May 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
Biopharmaceutical Neurology

HSMN NewsFeed - 24 Apr 2018
Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
Devices Neurology

HSMN NewsFeed - 21 Mar 2018
BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 8 Mar 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
Regenerative Medicine Neurology

HSMN NewsFeed - 2 Mar 2018
Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 31 Jan 2018
INSIGHTEC Closes $150 Million Series E Financing
Devices Venture Capital

HSMN NewsFeed - 31 Jan 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 22 Jan 2018
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 Dec 2017
Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Nov 2017
U.S. FDA Approves Kaléo's AUVI-Q(R) (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 26 Oct 2017
Intec Pharma Names Walt Linscott as Chief Administrative Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Oct 2017
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery

HSMN NewsFeed - 7 Sep 2017
Nexeon MedSystems Acquires Belgian Manufacturer
Devices Neurology Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Diagnostics Venture Capital

HSMN NewsFeed - 17 Aug 2017
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
Regenerative Medicine Personnel

HSMN NewsFeed - 2 Aug 2017
Collidion Acquires 80% Stake in Plex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Jul 2017
U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 27 Jul 2017
Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 17 Jul 2017
Enterin Inc. Raises $12.7 Million in Series A Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Biopharmaceutical Neurology Venture Capital

HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 23 Jun 2017
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix(R) (vortioxetine) sNDA
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jun 2017
Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Diagnostics Oncology Personnel

HSMN NewsFeed - 2 Jun 2017
Mylan Launches Generic Azilect(R) Tablets
Biopharmaceuticals Neurology Generics FDA Product Launch

HSMN NewsFeed - 3 May 2017
Intec Pharma Announces CEO Change
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Apr 2017
Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 Feb 2017
Pharma Two B Ltd. Closes $30 Million Financing Round
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 4 Jan 2017
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 19 Dec 2016
Tonix Pharmaceuticals’ PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation by the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Dec 2016
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment for Wet Age-related Macular Degeneration (Wet AMD)
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 25 Aug 2016
Mylan Taking Immediate Action to Further Enhance Access to EpiPen(R) (Epinephrine Injection, USP) Auto-Injector
Biopharmaceuticals Devices Drug Delivery Reimbursement

HSMN NewsFeed - 25 Aug 2016
Pivotal Study Results Published in New England Journal of Medicine (NEJM) Confirm Safety and Efficacy of INSIGHTEC's Exablate Neuro System for the Treatment of Essential Tremor
Devices Neurology

HSMN NewsFeed - 27 Jul 2016
Boston Scientific Announces Acquisition of Cosman Medical
Devices Neurology Mergers & Acquisitions

HSMN NewsFeed - 6 Jul 2016
NeuroDerm Announces Additions to Management Team
Biopharmaceuticals Devices Neurology Personnel

HSMN NewsFeed - 9 Jun 2016
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Jun 2016
Intec Pharma Announces Planned Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 3 May 2016
Intec Pharma Appoints VP of Clinical and Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 25 Apr 2016
Pharnext Announces the Opening of the First U.S. Study Site for its PLEO-CMT International Pivotal Phase 3 Trial in Charcot-Marie-Tooth Disease Type 1A
Biopharmaceuticals

HSMN NewsFeed - 15 Mar 2016
Nuviant Medical Names Brian Blischak Chief Commercial Officer
Devices Neurology Personnel

HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Feb 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 Feb 2016
Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 30 Dec 2015
NeuroDerm Announces Start of Patient Enrollment in Phase II Trial of ND0612H for Advanced Parkinson’s Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Dec 2015
Amarantus Requests Rare Pediatric Disease and Orphan Drug Designations from US FDA for Engineered Skin Substitute in the Treatment of Giant Congenital Melanocytic Nevi
Devices Regenerative Medicine Dermatology FDA

HSMN NewsFeed - 23 Dec 2015
VistaGen Secures Exclusive Worldwide Commercial Rights to Three Proprietary Stem Cell Technologies from University Health Network
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 6 Nov 2015
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
Devices Neurology

HSMN NewsFeed - 14 Oct 2015
Jzaneen Lalani Joins Curemark as Chief Operating Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 10 Sep 2015
Boston Scientific Announces CE Mark for the Vercise(TM) Primary Cell Deep Brain Stimulation System
Devices Neurology Regulatory

HSMN NewsFeed - 15 Jul 2015
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 15 May 2015
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 14 May 2015
Denali Therapeutics Launches with Initial Investment to Discover and Develop Treatments for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 13 Mar 2015
Minerva Neurosciences Announces $31 Million Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 14 Jan 2015
NeuroPhage Expands Series D Financing To $27 Million
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 24 Dec 2014
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel

HSMN NewsFeed - 11 Nov 2014
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2014
NeuroPhage Appoints Industry Veteran Franz Hefti, PhD, President/COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2014
AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2014
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2014
Boston Scientific Receives CE Mark For The Vercise(TM) Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
Devices Neurosurgery Regulatory

HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2014
GE Healthcare and CorTechs Labs Inc. Announce Strategic Agreement to Co-Market NeuroQuant(R), Comprehensive Solutions for Quantifying Brain Volume Loss
Devices Neurology Radiology Distribution

HSMN NewsFeed - 9 Apr 2014
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
Devices Neurology Distribution

HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 1 Apr 2014
Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 25 Mar 2014
Mazor Robotics Announces World's First Renaissance(R) Asleep Deep Brain Stimulation Procedure
Devices Surgery Neurology

HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 30 Jan 2014
Chelsea Therapeutics Names Keith W. Schmidt Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 29 Jan 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Biopharmaceuticals Neurology Cardiology Personnel

HSMN NewsFeed - 19 Nov 2013
Boston Scientific Vercise(TM) Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia
Devices Neurosurgery Regulatory

HSMN NewsFeed - 10 Sep 2013
Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 19 Aug 2013
ACADIA Pharmaceuticals Announces Appointment of Terrence Moore as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Aug 2013
New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy
Devices Neurology

HSMN NewsFeed - 25 Jul 2013
Mylan Announces STALEVO(R) Settlement Agreement
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 23 Jul 2013
XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing

HSMN NewsFeed - 18 Jun 2013
Boston Scientific Vercise(TM) DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
Devices Neurosurgery

HSMN NewsFeed - 17 May 2013
New Study Shows Effect of Neupro(R) (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
Biopharmaceuticals

HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Mar 2013
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin(TM) Program At American Academy Of Neurology Conference
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Mar 2013
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2012
Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfolio from Power3 Medical Products
Biopharmaceuticals Diagnostics Neurology Acquisitions

HSMN NewsFeed - 18 Dec 2012
FDA Clears IND For First Clinical Trial Protocol Developed Using Crowdsourcing
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 7 Dec 2012
Boston Scientific Receives European Regulatory Approval For New Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology Regulatory

HSMN NewsFeed - 4 Dec 2012
InSightec's ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
Devices Neurology Regulatory

HSMN NewsFeed - 4 Dec 2012
Elbit Imaging Ltd. Announces InSightec's ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
Devices Neurology Regulatory

HSMN NewsFeed - 14 Nov 2012
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR(R) and Donepezil for Alzheimer’s Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 2 Nov 2012
uniQure's Glybera(R) First Gene Therapy Approved by European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Oct 2012
Dr Roger M. Perlmutter Joins Heptares' Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2012
Amarantus BioSciences Appoints Clinton O. Allen To Advisory Board
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 28 Sep 2012
Boston Scientific Launches Vercise(TM) Deep Brain Stimulation System in Europe
Devices Neurology Regulatory

HSMN NewsFeed - 21 Sep 2012
Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to Develop Novel Treatments for Parkinson’s Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 Sep 2012
Higher dose of Novartis drug Exelon(R) Patch approved by FDA for patients with mild to moderate Alzheimer's disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 13 Aug 2012
Sanofi Announces FDA Approval for Auvi-Q(TM), First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 Jul 2012
First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery

HSMN NewsFeed - 30 May 2012
Echo Therapeutics Hires Marketing Executive
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 3 Apr 2012
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 20 Mar 2012
Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 19 Mar 2012
Merz Pharmaceuticals Introduces New Mederma(R) Advanced Scar Gel
Biopharmaceuticals Dermatology

HSMN NewsFeed - 15 Mar 2012
Medtronic Receives Health Canada License for Deep Brain Stimulation Therapy in Refractory Epilepsy Patients
Devices Neurology Regulatory

HSMN NewsFeed - 30 Jan 2012
Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera(R) Marketing Authorisation and Requests Further Information From the CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Jan 2012
Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Nov 2011
Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Sep 2011
ExAblate(R) Neuro has Been Used to treat 30 Patients with Chronic Neurological Disorders Such as Essential Tremor, Neuropathic Pain and Parkinson's Disease
Devices Neurology

HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 26 Aug 2011
Medistem Submits Response to FDA Clinical Hold
Regenerative Medicine FDA

HSMN NewsFeed - 16 Aug 2011
NeuroLogica Corporation Receives CE Mark for Its Portable, High-Resolution SPECT Camera, the inSPira HD(TM)
Devices Radiology Neurology Regulatory

HSMN NewsFeed - 8 Jul 2011
Amsterdam Molecular Therapeutics Files Glybera(R) European Marketing Application for Re-examination
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Jan 2011
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Jan 2011
Zogenix and Desitin Announce Marketing Approval for SUMAVEL(R) DosePro(TM) in Germany and the United Kingdom
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Jan 2011
Boston Scientific Acquires Intelect Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 23 Dec 2010
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 6 Dec 2010
Elan Names Robert A. Ingram Chairman-Designate
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Nov 2010
Ceregene Raises $11.5 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Nov 2010
Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease
Devices Neurology

HSMN NewsFeed - 8 Nov 2010
Lilly to Acquire Avid Radiopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Oct 2010
Integra LifeSciences Introduces the CRW Precision(TM) Arc Stereotactic System for Use in Stereotactic Frame-Based Neurosurgery
Devices Neurosurgery

HSMN NewsFeed - 16 Sep 2010
Medtronic Receives European CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy
Devices Neurology Regulatory

HSMN NewsFeed - 8 Sep 2010
iPierian Announces Second Close of $28 Million Series B Financing
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 3 Sep 2010
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Biopharmaceuticals

HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 8 Jul 2010
iPierian Closes $22 Million Series B Financing Led By Google Ventures
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals

HSMN NewsFeed - 17 Jun 2010
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 May 2010
BrainStorm Announces Significant Milestones Achieved and 2009 Review
Regenerative Medicine Neurology

HSMN NewsFeed - 26 Apr 2010
Aton Pharma Acquires Parkinson's Drug LODOSYN(R) (carbidopa)
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 23 Apr 2010
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Apr 2010
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery

HSMN NewsFeed - 23 Mar 2010
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 23 Mar 2010
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for World's Smallest Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Regulatory Neurology

HSMN NewsFeed - 12 Mar 2010
FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy
Devices Neurology FDA

HSMN NewsFeed - 10 Mar 2010
Diamyd Medical: Diamyd US Phase III Study Well under Way
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 22 Feb 2010
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 16 Feb 2010
Medtronic: Advanced Deep Brain Stimulation Therapy Now Available in Canada
Devices Neurology Neurosurgery Regulatory

HSMN NewsFeed - 9 Feb 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Diagnostics Ophthalmology Licensing

HSMN NewsFeed - 8 Feb 2010
Neuraltus Pharmaceuticals Names Andrew Gengos President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2009
AMT Announces Management Changes in Light of Refocused Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 2 Nov 2009
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
Devices Endocrinology

HSMN NewsFeed - 12 Oct 2009
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Oct 2009
Pico-Tesla Starts Phase III Clinical Trial of Its Proprietary Magnetic (Magneceutical) Therapy for Parkinson's Disease
Devices Neurology

HSMN NewsFeed - 28 Sep 2009
Abbott to Acquire Solvay Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Sep 2009
St. Jude Medical Receives CE Mark Approval for World's Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Neurology Regulatory

HSMN NewsFeed - 3 Sep 2009
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 1 Sep 2009
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 31 Aug 2009
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
Devices Neurosurgery

HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2009
Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Aug 2009
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Jul 2009
Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
Devices Neurology FDA

HSMN NewsFeed - 14 Jul 2009
St. Jude Medical Announces Australian TGA Regulatory Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
Devices Neurology Regulatory

HSMN NewsFeed - 14 Jul 2009
A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders
Devices Neurosurgery

HSMN NewsFeed - 12 Jun 2009
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly Improved Early Morning akinesia and was Generally Well Tolerated Over Four Years
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Jun 2009
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson's Disease
Devices Neurology

HSMN NewsFeed - 29 May 2009
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 28 May 2009
Power3 Medical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer's
Diagnostics Neurology

HSMN NewsFeed - 18 May 2009
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
Diagnostics Neurology

HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 14 May 2009
Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 May 2009
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Diagnostics Neurology

HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 May 2009
Teva Announces Extension of Patent Protection for Azilect
Biopharmaceuticals Neurology Generics

HSMN NewsFeed - 15 Apr 2009
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 10 Apr 2009
New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Mar 2009
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 18 Mar 2009
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
Diagnostics Neurology

HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Jan 2009
St. Jude Medical Announces European CE Mark Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
Devices Neurology Regulatory

HSMN NewsFeed - 9 Jan 2009
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 12 Nov 2008
Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
Devices Neurology Venture Capital

HSMN NewsFeed - 21 Oct 2008
GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Sep 2008
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Sep 2008
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
Devices

HSMN NewsFeed - 18 Sep 2008
The European Commission Grants Orphan Drug Designation to Alseres Pharmaceuticals' Spinal Cord Injury Treatment, Cethrin(R)
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 16 Sep 2008
GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
Biopharmaceuticals

HSMN NewsFeed - 15 Sep 2008
Keppra XR(TM) Approved in the U.S.
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Sep 2008
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 26 Aug 2008
ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2008
Medtronic Launches First Insertable Cardiac Monitor in Japan
Devices Cardiology Monitoring Regulatory

HSMN NewsFeed - 13 Jun 2008
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Jun 2008
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
Biopharmaceuticals

HSMN NewsFeed - 23 May 2008
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2008
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Apr 2008
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2008
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Biopharmaceuticals Diagnostics Neurology

HSMN NewsFeed - 17 Apr 2008
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
Biopharmaceuticals

HSMN NewsFeed - 16 Apr 2008
Medtronic Activa(R) Deep Brain Stimulation Patient Referral Advisor Software Launched in United States
Devices Neurology

HSMN NewsFeed - 14 Apr 2008
Vasogen Announces Implementation of Strategic Restructuring Plan
Biopharmaceuticals

HSMN NewsFeed - 14 Apr 2008
Stem Cells From Menstrual Blood Show Therapeutic Potential
Regenerative Medicine

HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2008
ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
Biopharmaceuticals

HSMN NewsFeed - 20 Mar 2008
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
Biopharmaceuticals Neurology Product Recall

HSMN NewsFeed - 28 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Feb 2008
Integra LifeSciences Introduces Titanium Skull Pins for Intra-Operative Brain Surgery
Devices Neurosurgery

HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Feb 2008
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 7 Feb 2008
Chelsea Therapeutics Begins Patient Dosing in Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2008
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
Diagnostics Personnel

HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Dec 2007
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 5 Dec 2007
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Nov 2007
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
Regenerative Medicine Neurology Licensing

HSMN NewsFeed - 19 Nov 2007
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Nov 2007
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
Regenerative Medicine Neurology

HSMN NewsFeed - 1 Nov 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 Oct 2007
Neurogen Corporation Announces Appointment of Kenneth J. Sprenger to Vice President, Clinical Development and Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2007
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 10 Oct 2007
Amarin Announces Initiation of Cardiovascular Development Strategy
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2007
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2007
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
Regenerative Medicine Neurology

HSMN NewsFeed - 8 Oct 2007
AVANIR Granted Special Protocol Assessment (SPA) From FDA for Confirmatory Phase III Trial of Zenvia in Patients With PBA
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Oct 2007
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery

HSMN NewsFeed - 8 Oct 2007
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery

HSMN NewsFeed - 28 Sep 2007
Santhera Announces Start of US Phase III Clinical Trial with SNT-MC17 in Friedreich's Ataxia and Provides Details on Study Design
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 26 Sep 2007
EnVivo Pharmaceuticals Announces Executive Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2007
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Sep 2007
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
Regenerative Medicine Neurology Litigation

HSMN NewsFeed - 18 Sep 2007
Valeant Pharmaceuticals Announces the Launch of the zelaCARD for Parkinson's Disease Patients Taking Zelapar(R)
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Sep 2007
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2007
BrainStorm Cell Therapeutics Takes Initial Steps Toward FDA Submission
Regenerative Medicine Neurology

HSMN NewsFeed - 30 Aug 2007
Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2007
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2007
Prestwick Pharmaceuticals, Inc. Strengthens Management Team with Appointment of Robert S. Radie as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Aug 2007
Stem Cell Therapy International Acquires Exclusive Worldwide Rights to New, Anti-Rejection Stem Cell Technology
Regenerative Medicine

HSMN NewsFeed - 31 Jul 2007
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
Biopharmaceuticals Acquisitions Neurology

HSMN NewsFeed - 30 Jul 2007
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
Biopharmaceuticals Devices Drug Delivery Neurology

HSMN NewsFeed - 23 Jul 2007
NeuroDerm Raises $2.5 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Jul 2007
Panacea Pharmaceuticals Announces the Availability of LC Detect(sm), a Serum-Based Diagnostic Test for Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 16 Jul 2007
UCB Announces the U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Jul 2007
BrainStorm Cell Therapeutics Elects Moshe Lion to Its Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 16 Jul 2007
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Jun 2007
Avicena to Advance Huntington's Disease Clinical Program into Phase III
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Jun 2007
Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Jun 2007
Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Jun 2007
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Jun 2007
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jun 2007
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
Biopharmaceuticals Radiology

HSMN NewsFeed - 19 Jun 2007
Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Jun 2007
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
Diagnostics Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Jun 2007
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jun 2007
Washington Hospital Healthcare System First in the United States to Treat Patients Using the New Leksell(R) Gamma Knife Perfexion(TM)
Devices Oncology Neurosurgery

HSMN NewsFeed - 11 Jun 2007
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
Devices Neurology Venture Capital

HSMN NewsFeed - 8 Jun 2007
Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc.
Biopharmaceuticals

HSMN NewsFeed - 8 Jun 2007
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jun 2007
In 2009 Exonhit Aims to ask for Market Clearance in Europe for a Blood Diagnostic Test for Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2007
Panacea Pharmaceuticals Announces the Availability of PC Detect(sm) for Prostate Cancer Screening
Diagnostics Oncology

HSMN NewsFeed - 30 May 2007
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
Regenerative Medicine

HSMN NewsFeed - 30 May 2007
Neuro-Hitech, Inc., Obtains Exclusive License to Combination Drugs for the Treatment of Alzheimer's Disease and Other Serious Neurological Disorders
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2007
New Agreement Boosts Pipeline for Synosia Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 17 May 2007
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
Devices Personnel

HSMN NewsFeed - 10 May 2007
NeuroVista Raises $33.8 Million in Series B Financing
Devices Neurology Venture Capital

HSMN NewsFeed - 10 May 2007
FDA Approves SCHWARZ PHARMA's Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 9 May 2007
Avid Radiopharmaceuticals Closes $26 Million Series C Financing
Biopharmaceuticals Radiology Neurology Venture Capital

HSMN NewsFeed - 8 May 2007
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
CleveMed Receives FDA Clearance to Market Wireless Movement Disorder Monitor
Devices Neurology Monitoring

HSMN NewsFeed - 30 Apr 2007
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
Devices Neurosurgery Oncology

HSMN NewsFeed - 27 Apr 2007
Meda Acquires Product Portfolio from the US Pharma Company Wyeth
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Apr 2007
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Apr 2007
William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 19 Apr 2007
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases after Receiving CLIA High-Complexity Certification
Diagnostics Personnel

HSMN NewsFeed - 17 Apr 2007
Integra LifeSciences Releases New Brain Mapping Software to Treat Parkinson's Disease
Devices Neurology

HSMN NewsFeed - 16 Apr 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Apr 2007
Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Apr 2007
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Apr 2007
Medtronic Wins Medical Design Excellence Awards for Products Related to Activa(R) Deep Brain Stimulation Therapy and Ear, Nose and Throat Surgery
Devices

HSMN NewsFeed - 10 Apr 2007
Amarin Appoints Declan Doogan to New Position of President-Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2007
John Conron Joins Neuralstem as Chief Financial Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 6 Apr 2007
Exciting Developments on the Horizon for Parkinson Disease, Says Medical Director for the National Parkinson Foundation
Biopharmaceuticals Regenerative Medicine Neurology

HSMN NewsFeed - 5 Apr 2007
One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United States
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Apr 2007
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2007
Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Mar 2007
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Mar 2007
Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of Directors
Devices Personnel

HSMN NewsFeed - 22 Mar 2007
Avicena Announces Patient Enrollment in National Institutes of Health (NIH) Phase III Parkinson's Disease Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Biopharmaceuticals Radiology Neurology

HSMN NewsFeed - 19 Mar 2007
Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 16 Mar 2007
Neuralstem Inc. Raises $5 Million in a Private Placement
Regenerative Medicine Neurology

HSMN NewsFeed - 6 Mar 2007
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
Biopharmaceuticals Drug Delivery Neurology Licensing

HSMN NewsFeed - 27 Feb 2007
Amarin Appoints Professor William Hall as Non-Executive Director
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 22 Feb 2007
Cardiome Announces Management Appointments
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 20 Feb 2007
Vyteris Announces Senior Staff Promotions
Devices Drug Delivery Personnel

HSMN NewsFeed - 5 Feb 2007
Amarin Announces Completion of Two Phase III Trials With Miraxion in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Jan 2007
Proneuron Announces the Receipt of a $430,000 Grant from the Michael J. Fox Foundation to Develop Its PN277 for the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Jan 2007
Amicus Therapeutics Receives Grant From Michael J. Fox Foundation for Parkinson's Research
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jan 2007
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
Biopharmaceuticals Radiology Licensing

HSMN NewsFeed - 11 Jan 2007
Neuralstem Licenses Out Compounds for Diabetes Treatment
Regenerative Medicine Licensing

HSMN NewsFeed - 10 Jan 2007
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2007
Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exclusive Worldwide License
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 3 Jan 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data in Neurology
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Dec 2006
Avicena Signs Agreement with the National Institute of Neurological Disorders and Stroke for Phase III Trial for Novel Parkinson's Disease Candidate
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Nov 2006
Stem Cell Therapy International Reports the Successful Treatment of a Stroke Patient With Their Proprietary Stem Cell Transplantation Therapy
Regenerative Medicine Neurology

HSMN NewsFeed - 28 Nov 2006
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
Biopharmacetuicals Licensing

HSMN NewsFeed - 17 Nov 2006
Neuro-Hitech Announces Agreement to Acquire Q-RNA, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 10 Nov 2006
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Nov 2006
Raptor Pharmaceuticals Corp. Announces an Exclusive Worldwide License Agreement for Mesd Reagents for Treatment of Cancer and Osteoporosis
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Nov 2006
Gladstone Institutes and Merck & Co., Inc. Announce Major Research Collaboration and Exclusive License Agreement in Field of Apolipoprotein (Apo) E
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 31 Oct 2006
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Oct 2006
Stem Cell Treatment Proven to Reduce Parkinson's Symptoms
Regenerative Medicine Neurology

HSMN NewsFeed - 16 Oct 2006
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 11 Oct 2006
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 28 Sep 2006
New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Sep 2006
Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent
Biopharmaceuticals Radiology Neurology

HSMN NewsFeed - 21 Sep 2006
Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2006
NuPathe Closes $15 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Sep 2006
Omeros Acquires Nura
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 Jul 2006
Stem Cell Authority Ltd.(TM) Offers Ethical Alternative to Alleviate Political Stem Cell Deadlock Between U.S. Congress and President
Regenerative Medicine

HSMN NewsFeed - 20 Jul 2006
SmartPill Wins 510(k) Release from FDA
Devices Gastroenterology FDA

HSMN NewsFeed - 20 Jul 2006
Stem Cell Therapy International Names Lixian (John) Jiang, Chief Operating Officer, China Division
Regenerative Medicine Personnel

HSMN NewsFeed - 19 Jul 2006
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Jul 2006
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Jun 2006
Amarin Completes Target Patient Enrollment in North American Phase III Trial of Miraxion(TM) in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Jun 2006
Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2006
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 25 May 2006
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 May 2006
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
Amarin Acquires Parkinson's Disease Drug Candidate
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 11 May 2006
Boston Life Sciences, Inc. Solidifies Comprehensive Axon Regeneration Position with Children's Hospital Boston
Biopharmaceuticals Neurology Regenerative Medicine

HSMN NewsFeed - 11 May 2006
Stem Cell Therapeutics Corp. Announces Issuance of Second US Patent
Regenerative Medicine

HSMN NewsFeed - 9 May 2006
Avicena Announces Phase III ALS Trial Results
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 May 2006
VSM reports progress on using MEG for diagnosing Alzheimer's and Parkinson's
Devices Neurology

HSMN NewsFeed - 5 May 2006
Questcor Announces the Acquisition of Doral(R) (quazepam)
Biopharmaceuticals Neurology Acquisitions

Return to NewsFeed

Additional items found! 288

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 288 additional stories matching:
Parkinson's disease
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.